Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted …
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Alector(ALEC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.48 (USD) 04/15/2021 Weighted Valuation$18.21 (USD) Overall RatingFairly valued to slightly Overvalued by 1.5% Valuation Models Comparables: $14.55 (USD) …
Alector (ALEC:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Altimmune(ALT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.73 (USD) 04/15/2021 Weighted Valuation$9.89 (USD) Overall RatingOvervalued by 22.3% Valuation Models Comparables: $15.08 (USD) (in order of …
Altimmune (ALT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Aclaris Therapeutics(ACRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.82 (USD) 04/14/2021 Weighted Valuation$9.19 (USD) Overall RatingOvervalued by 67.0% Valuation Models Comparables: $9.19 (USD) Valuation Methods …
Aclaris Therapeutics (ACRS:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Akebia Therapeutics(AKBA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.12 (USD) 04/14/2021 Weighted Valuation$3.53 (USD) Overall RatingUndervalued by 13.4% Valuation Models Adjusted Book Value: $3.53 (USD) …
Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Mersana Therapeutics(MRSN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$16.63 (USD) 03/26/2021 Weighted Valuation$15.75 (USD) Overall RatingOvervalued by 5.3% Valuation Models Adjusted Book Value: $15.10 (USD) …
Mersana Therapeutics (MRSN:NAS) Fundamental Valuation Report Read more »
Read More
Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …
PEDEVCO (PED:ASE) and New Concept Energy (GBR:ASE) Are Biggest Stock Gainers YTD on AMEX Read more »
Read More
Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …
Pfenex (PFNX:ASE) and BioPharmX (BPMX:ASE) Are Biggest Stock Gainers YTD on AMEX Read more »
Read More
Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …
BioPharmX (BPMX:ASE) and FTE Networks (FTNW:ASE) Are Biggest Stock Gainers YTD on AMEX Read more »
Read More
Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …
Cormedix (CRMD:ASE) and Pfenex (PFNX:ASE) Are Biggest Stock Decliners YTD on AMEX Read more »
Read More